Stockscreener 앱 받기
20.66
1.90%
-0.40
시간 외 거래:
20.66
전일 마감가:
$21.06
열려 있는:
$20.88
하루 거래량:
978.55K
Relative Volume:
1.58
시가총액:
$1.49B
수익:
$434.49M
순이익/손실:
$504.34M
주가수익비율:
3.4354
EPS:
6.0138
순현금흐름:
$181.97M
1주 성능:
-0.58%
1개월 성능:
+2.08%
6개월 성능:
-12.01%
1년 성능:
+13.14%
1일 변동 폭
$20.51
$20.94
1주일 범위
$20.51
$21.49
52주 변동 폭
$17.45
$25.14
Innoviva Inc Stock (INVA) Company Profile
명칭
Innoviva Inc
전화
(650) 238-9600
주소
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, MRNA, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
20.66 | 1.49B | 434.49M | 504.34M | 181.97M | 6.0138 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-09-23 | 재개 | Oppenheimer | Outperform |
| 2026-02-17 | 개시 | BTIG Research | Buy |
| 2025-09-30 | 개시 | Goldman | Sell |
| 2025-08-11 | 개시 | Oppenheimer | Outperform |
| 2025-07-14 | 개시 | H.C. Wainwright | Buy |
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-07-20 | 개시 | Goldman | Neutral |
| 2017-11-20 | 개시 | Deutsche Bank | Hold |
모두보기
Innoviva Inc 주식(INVA)의 최신 뉴스
Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026 - Stock Titan
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
INVA vs. MRK: Which Stock Is the Better Value Option? - Zacks Investment Research
5 Attractive Low Price-to-Sales Stocks With Promising Upside Potential - Zacks Investment Research
Should Value Investors Buy Innoviva (INVA) Stock? - Zacks Investment Research
Understanding Momentum Shifts in (INVA) - Stock Traders Daily
Innoviva at Cantor conference: growth bets beyond COPD royalties - investing.com
Innoviva at Cantor conference: growth bets beyond COPD royalties By Investing.com - Investing.com India
INVA - Finviz
Innoviva to Participate in Upcoming September 2026 Investor Conferences - biospace.com
Innoviva to Participate in Upcoming Investor Conferences - finance.yahoo.com
INVA Q2 2026 Earnings: EPS Misses by 356% as Loss Hits $1.14Consensus Forecast Report - vinanet.vn
(INVA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Entasis Therapeutics Holdings Inc. (ETTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Innoviva CEO Pavel Raifeld Executes Tax-Related Share Withholding Transaction - Kalkine Media
Innoviva (NASDAQ: INVA) CFO now holds 88,013 shares after tax withholding - Stock Titan
Innoviva (NASDAQ: INVA) CEO sees 1,130 shares withheld for taxes - Stock Titan
Innoviva CFO Stephen Basso Reports Share Withholding Transaction to Cover Taxes on August 2026 Equity Vesting - Kalkine Media
Cantor Fitzgerald reiterates Innoviva stock rating at overweight By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Innoviva stock rating at overweight - Investing.com
Cantor Fitzgerald reiterates Innoviva stock rating at overweight By Investing.com - Investing.com UK
NewEdge Wealth LLC Acquires New Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Innoviva (INVA) Snapshot: Posts a 2.23% Loss to $21.00 in Latest Trading; the Session Ends Within the Reported Technical Boundaries on the DayWedge Breakout - vinanet.vn
Innoviva (INVA) Snapshot: Posts a 2.23% Loss to $21.00 in Latest Trading; the Session Ends Within the Reported Technical Boundaries on the DayWedge Breakout - dars.gov.et
70,000 Shares in Innoviva, Inc. $INVA Purchased by Chase Investment Counsel Corp - MarketBeat
Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
Innoviva, Inc.: Target Price Consensus and Analysts Recommendations | INVA | US45781M1018 - marketscreener.com
Bank of America Corp DE Has $37.75 Million Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva (INVA) Holds Near $20.87 After Modest 0.29% GainSuperTrend - vinanet.vn
Innoviva (INVA) Holds Near $20.87 After Modest 0.29% GainSupply Zone - dars.gov.et
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo! Finance Canada
Innoviva (INVA) Holds Near $20.81 as Biopharma Royalty Stock Stays RangeboundVolatility Smile - vinanet.vn
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo Finance
HC Wainwright Issues Positive Forecast for Innoviva Earnings - MarketBeat
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com Australia
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com India
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com Canada
Three Innoviva therapies named finalists for Prix Galien award - Investing.com
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com UK
Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award - Business Wire
Innoviva, Inc. (INVA) Stock Analysis: Uncovering a 69% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
How (INVA) Movements Inform Risk Allocation Models - Stock Traders Daily
Innoviva (INVA) Holds Steady at $20.68: Key Support and Resistance in FocusJelly Roll Trade - dars.gov.et
Does Innoviva’s Q2 Loss and Buyback-Fueled EPS Shift Change The Bull Case For INVA? - webull.com
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo! Finance Canada
Innoviva stock price target reiterated at $46 by H.C. Wainwright - Investing.com Nigeria
Innoviva stock price target reiterated at $46 by H.C. Wainwright - Investing.com
Innoviva stock price target reiterated at $46 by H.C. Wainwright - Investing.com UK
Innoviva Inc (INVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.58%
3.37%
자본화:
|
볼륨(24시간):